No, the symptom is being treated, not the underlying issue. And that's ok, but treating the underlying issue, when possible, is better, as the problem ceases to exist.
For many people, the "underlying issue" is fundamentally just being too hungry for how they live. GLP-1s absolutely treat that.
> No, the symptom is being treated, not the underlying issue.
That's a semantic argument. The "issue", medically, to most people viewing this as a health problem, is excess body fat and not eating behavior.
I mean, you're not wrong, but this seems silly. YES, it would be better to have developed a cure for disordered and unrestrained eating. We didn't. And we don't really even know how. Oops, as it were. But we do have a treatment that avoids the most significant impacts of those problems.
Medicine is harder than software engineering. Not all bugs are shallow even with all the eyes in the world.
But that's not what the pharma companies want. They want you on the lifetime prescriptions that don't actually address the underlying problem.